Transgene Biotek Limited (TRABI.BO)

INR 3.91

(0.0%)

Inventory Summary of Transgene Biotek Limited

Transgene Biotek Limited's latest annual inventory in 2023 was 339 Thousand INR , up 0.41% from previous year.
Transgene Biotek Limited's latest quarterly inventory in 2023 FY was 339 Thousand INR , up 0.41% from previous quarter.
Transgene Biotek Limited reported annual inventory of 337.6 Thousand INR in 2022, down -64.32% from previous year.
Transgene Biotek Limited reported annual inventory of 946.22 Thousand INR in 2021, up 361.35% from previous year.
Transgene Biotek Limited reported quarterly inventory of 339.04 Thousand INR for 2023 Q2, down 0.0% from previous quarter.
Transgene Biotek Limited reported quarterly inventory of 339 Thousand INR for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of Transgene Biotek Limited (2023 - 2006)

Historical Annual Inventory of Transgene Biotek Limited (2023 - 2006)

Year	Inventory	Inventory Growth
2023	339 Thousand INR	0.41%
2022	337.6 Thousand INR	-64.32%
2021	946.22 Thousand INR	361.35%
2020	205.1 Thousand INR	-46.63%
2019	384.31 Thousand INR	23.61%
2018	310.91 Thousand INR	-26.13%
2017	420.91 Thousand INR	-35.64%
2016	654.04 Thousand INR	0.0%
2015	654.04 Thousand INR	-1.13%
2014	661.54 Thousand INR	-8.42%
2013	722.37 Thousand INR	-70.83%
2012	2.47 Million INR	-69.94%
2011	8.23 Million INR	-8.93%
2010	9.04 Million INR	5850.88%
2009	152 Thousand INR	-99.51%
2008	31.31 Million INR	-0.12%
2007	31.35 Million INR	11331.75%
2006	274.29 Thousand INR	0.0%

Year	Inventory	Inventory Growth
2023 FY	339 Thousand INR	0.41%
2023 Q2	339.04 Thousand INR	0.0%
2023 Q4	339 Thousand INR	0.0%
2023 Q3	- INR	-100.0%
2023 Q1	- INR	-100.0%
2022 Q4	337.6 Thousand INR	0.0%
2022 FY	337.6 Thousand INR	-64.32%
2022 Q1	- INR	-100.0%
2022 Q2	946.22 Thousand INR	0.0%
2022 Q3	- INR	-100.0%
2021 Q4	946.22 Thousand INR	0.0%
2021 Q2	205.1 Thousand INR	0.0%
2021 FY	946.22 Thousand INR	361.35%
2021 Q1	- INR	-100.0%
2021 Q3	- INR	-100.0%
2020 FY	205.1 Thousand INR	-46.63%
2020 Q1	- INR	-100.0%
2020 Q3	- INR	-100.0%
2020 Q2	384.31 Thousand INR	0.0%
2020 Q4	205.1 Thousand INR	0.0%
2019 Q3	- INR	-100.0%
2019 FY	384.31 Thousand INR	23.61%
2019 Q2	310.91 Thousand INR	0.0%
2019 Q4	384.31 Thousand INR	0.0%
2018 FY	310.91 Thousand INR	-26.13%
2018 Q1	- INR	0.0%
2018 Q4	310.91 Thousand INR	0.0%
2017 FY	420.91 Thousand INR	-35.64%
2016 FY	654.04 Thousand INR	0.0%
2015 FY	654.04 Thousand INR	-1.13%
2014 FY	661.54 Thousand INR	-8.42%
2013 FY	722.37 Thousand INR	-70.83%
2012 FY	2.47 Million INR	-69.94%
2012 Q1	8.23 Million INR	0.0%
2012 Q2	15.42 Million INR	87.21%
2012 Q4	2.47 Million INR	-83.22%
2012 Q3	14.75 Million INR	-4.31%
2011 FY	8.23 Million INR	-8.93%
2010 FY	9.04 Million INR	5850.88%
2009 FY	152 Thousand INR	-99.51%
2008 FY	31.31 Million INR	-0.12%
2007 FY	31.35 Million INR	11331.75%
2006 FY	274.29 Thousand INR	0.0%

Peer Inventory Comparison of Transgene Biotek Limited

Name	Inventory	Inventory Difference
Alfavision Overseas (India) Limited	- INR	-Infinity%
Biocon Limited	49.43 Billion INR	99.999%
Blue Jet Healthcare Limited	1.29 Billion INR	99.974%
Concord Biotech Limited	2.07 Billion INR	99.984%
Dishman Carbogen Amcis Limited	8.82 Billion INR	99.996%
FERMENTA BIOTECH LIMITED	890.74 Million INR	99.962%
GENOMIC VALLEY BIOTECH LIMITED	1.00 INR	-33899900.0%
Lyka Labs Limited	95.71 Million INR	99.646%
Panacea Biotec Limited	1.77 Billion INR	99.981%
SAMSRITA LABS LIMITED	1.00 INR	-33899900.0%
Servoteach Industries Limited	- INR	-Infinity%
SMS Lifesciences India Limited	812.1 Million INR	99.958%
Supriya Lifescience Limited	852.49 Million INR	99.96%
Syngene International Limited	2.38 Billion INR	99.986%
TAKE Solutions Limited	7.96 Million INR	95.741%
Titan Biotech Limited	455.71 Million INR	99.926%
Vanta Bioscience Limited	75.2 Million INR	99.549%